| Literature DB >> 34409536 |
Stefan Rakete1, Given Moonga2,3,4, Anna-Maria Wahl2, Viola Mambrey2, Dennis Shoko5, Dingani Moyo6,7, Shamiso Muteti-Fana8, Myriam Tobollik9, Nadine Steckling-Muschack2, Stephan Bose-O'Reilly2,10,11.
Abstract
People living and working in artisanal and small-scale gold mining (ASGM) areas are frequently exposed to elemental mercury (Hg), which is used for gold extraction. However, additional exposure to other toxic metals such as arsenic (As), cadmium (Cd) and lead (Pb) may result from mining-related activities and could be ingested via dust, water or food. In these areas, only limited biomonitoring data is available for toxic metals other than Hg. In particular, data about the exposure to As, Cd and Pb is unavailable for the Zimbabwean population. Therefore, we conducted a cross-sectional study in two ASGM areas in Zimbabwe to evaluate the internal exposure to these metals. In total, urine and blood samples from 207 people that identified themselves as miners were collected and analysed for As and Cd in urine as well as Pb in blood by GF-AAS. Median levels (interquartile ranges in μg/l) of As and Pb were 9.7 μg/l (4.0, 18.5) and 19.7 μg/l (12.5, 34.5), respectively. The 25th percentile and the median for Cd were below the limit of detection (0.5 μg/l); the 75th percentile was at 0.9 μg/l. The results were compared to reference values found for the general population in the USA and Germany, and a significant number of participants exceeded these values (As, 33 %; Cd, 27 %; Pb, 32 %), indicating a relevant exposure to toxic metals. Although not representative for the Zimbabwean population, our results demonstrate that the exposure to toxic metals is relevant for the public health in Zimbabwe and requires further investigation.Entities:
Keywords: Arsenic; Artisanal and small-scale gold mining; Biomonitoring; Cadmium; Lead; Toxic metals; Zimbabwe
Mesh:
Substances:
Year: 2021 PMID: 34409536 PMCID: PMC8741681 DOI: 10.1007/s11356-021-15940-w
Source DB: PubMed Journal: Environ Sci Pollut Res Int ISSN: 0944-1344 Impact factor: 4.223
Demographic information on the study population
| Age | 207 | ||
|---|---|---|---|
| Median (min.–max.) | 38 (18–77) | ||
| Gender | Males | 169 | (81.6) |
| Females | 38 | (18.4) | |
| Living area | Kadoma | 131 | (63.3) |
| Shurugwi | 76 | (36.7) | |
| Fish consumption | < once a week | 42 | (20.3) |
| > once a week | 165 | (79.7) |
Descriptive analysis of biomonitoring results for urinary levels of As and Cd and blood levels of Pb. Creatinine correction was not applied for urine samples with creatinine levels below 0.3 or above 3.0 g/l. Results were compared to international reference and threshold values for As and Cd in urine and Pb in blood, and the percentage of exceedances in this study is given in the brackets. Reference values represent the actual internal exposure of a representative population. Threshold values were derived from toxicological data. NHANES National Health and Nutrition Examination Survey, USA, UBA German Environment Agency, CDC Centers for Disease Control and Prevention, USA, NIOSH National Institute for Occupational Safety and Health, USA, HBM-II human biological monitoring alert level (Centers of Disease Preventions and Control (CDC) 2019, Schulz et al. 2011, UBA - German Environment Agency 2019)
| Creatinine in urine | As in urine | Cd in urine | Pb in blood | |||
|---|---|---|---|---|---|---|
| g/l | μg/l | μg/g crea. | μg/l | μg/g crea. | μg/l | |
| N | 206 | 206 | 193 | 206 | 193 | 206 |
| LOD | 0.1 | 0.5 | 0.5 | 1 | ||
| < LOD | 0 | 12 | 120 | 0 | ||
| GM | 1,3 | 7.2 | 5.6 | 0.6 | 0.4 | 21.9 |
| Minimum | 0.1 | < LOD | < LOD | 6.6 | ||
| 25th percentile | 1.0 | 3.7 | 2.7 | < LOD | 12.5 | |
| Median | 1.4 | 9.7 | 6.5 | < LOD | 19.7 | |
| 75th percentile | 2.0 | 17.1 | 13.2 | 0.9 | 0.7 | 34.1 |
| 95th percentile | 2.8 | 47.1 | 33.6 | 3.6 | 1.8 | 76.4 |
| Maximum | 4.6 | 460.5 | 250.3 | 11.4 | 4.9 | 275.7 |
| As in urine [μg/l] | Cd in urine [μg/l] | Pb in blood [μg/l] | ||||
| Reference values (exceedances in %) | ||||||
| NHANES | 49.9 (3.6) | 1.1 (22) | 28.9 (32) | |||
| UBA | 15.0 (33) | 0.8 (27) | 30 (♀, 24 %) 40 (♂, 20 %) | |||
| Threshold values (exceedances in %) | ||||||
| NIOSH (CDC) | n.a. | n.a | 50 (11) | |||
| UBA (HBM-II) | n.a. | 4.0 (4) | n.a. | |||
LOD limit of detection, < LOD number of results below limit of detection, GM geometric mean, n.a. not available
Comparison of the study results (all values are given in μg/l) with other studies in mining areas. All values are given as 25th percentile (P25), median and 75th percentile (P75) unless marked otherwise (#)
| Parameter [μg/l] | Values measured in this Study | Values measured in studies in current and former mining areas (country) | Reference |
|---|---|---|---|
| P25–median–P75 | P25–median–P75 | ||
| As in urine | 4.0–10.0–18.5 | 4.9–9.4–15.1 (Tanzania)1 | Nyanza et al. ( |
| 73.2–100.2–135.3 (Ghana) | Basu et al. ( | ||
| 11.1–16.5–19.4 (Mexico)2 | Moreno et al. ( | ||
| 0.5–1.17–1.93 (Spain)2 | Molina-Villalba et al. ( | ||
| 0.06 (Guatemala) | Basu et al. ( | ||
| Cd in urine | < LOD–< LOD–0.9 | 0.25–0.36–0.6 (Ghana) | Basu et al. ( |
| 0.13–0.29–0.46 (Spain)2 | Molina-Villalba et al. ( | ||
| 0.11 (Guatemala) | Basu et al. ( | ||
| Pb in blood | 12.5–19.9–34.5 | 16.9–25.4–33.7 (Tanzania)1 | Nyanza et al. ( |
| 64–94–113 (Mexico)2 | Moreno et al. ( | ||
| 26.7 (Guatemala) | Basu et al. ( | ||
| 13.0 (Zambia) | Yabe et al. ( | ||
| 21.5 (Nigeria) | Gottesfeld et al. ( | ||
| 28.0 (Ghana)# | Obiri et al. ( |
1Pregnant women
2Children
#Mean
LOD limit of detection